ARTICLE | Company News
Intercell, Solvo Biotechnology Inc. deal
June 28, 2004 7:00 AM UTC
Solvo licensed exclusive rights from Intercell to progesterone-induced blocking factor (PIBF) technology for diagnostic purposes. Under the two-year project, Solvo will develop an ELISA-based diagnost...